Regis Healthcare Limited (ASX:REG)
6.39
+0.01 (0.16%)
Aug 21, 2026, 4:10 PM AEST
Regis Healthcare Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Regis Healthcare stock has a consensus rating of "Buy" and an average price target of $7.69. The average 1-year stock price forecast is 20.34% higher than the current stock price, while the lowest is $7.00 (+9.55%) and the highest is $8.60 (+34.59%).
Price Target: $7.69 (+20.34%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Regis Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 2 | 1 | 1 |
| Hold | 2 | 2 | 2 | 1 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Macquarie No rating | Macquarie | Buy Maintains $7.90 | Buy | Maintains | $7.90 | +23.63% | Jul 31, 2026 |
| Jefferies | Jefferies | Buy Maintains $8.00 → $7.95 | Buy | Maintains | $8.00 → $7.95 | +24.41% | Jul 29, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $7.50 | Buy | Maintains | $7.50 | +17.37% | Jul 16, 2026 |
| UBS | UBS | Hold Maintains $7.00 | Hold | Maintains | $7.00 | +9.55% | Jul 8, 2026 |
| Jarden | Jarden | Hold Downgrades $8.50 → $7.50 | Hold | Downgrades | $8.50 → $7.50 | +17.37% | Jun 18, 2026 |
Financial Forecast
Revenue This Year
1.38B
from 1.16B
Increased by 18.94%
Revenue Next Year
1.50B
from 1.38B
Increased by 8.53%
EPS This Year
0.18
from 0.17
Increased by 6.48%
EPS Next Year
0.23
from 0.18
Increased by 26.86%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.